Neoadjuvant chemo-immunotherapy in mismatch repair deficient (dMMR)/microsatellite instability (MSI) gastric carcinoma (GC): A multicenter retrospective study

被引：0

作者：

Sun, H. ^{[1
]}

Moiseyenko, V. ^{[2
]}

Chubenko, V. ^{[2
]}

Gerk, I. ^{[2
]}

Navmatulya, A. ^{[3
]}

Shelekhova, K. V. ^{[4
]}

Volkov, N. M. ^{[2
]}

Zykov, E. ^{[5
]}

Chernobrivceva, V. ^{[6
]}

Nered, S.

Besova, N. ^{[7
]}

Obarevich, E. ^{[7
]}

Gavrilova, D. ^{[7
]}

Kononets, P.

Stilidi, I.

Belyak, N. ^{[8
]}

Orlova, R. V. ^{[9
]}

Topuzov, E. ^{[10
]}

Pelipas, Y. ^{[10
]}

Tryakin, A. ^{[7
]}

机构：

[1] NN Blokhin Natl Med Res Ctr Oncol, Abdominal Oncol, Moscow, Russia

[2] Napalkov State Budgetary Healthcare Inst, Dept Oncol, St Petersburg Clin Sci & Pract Ctr Specialized Ty, St Petersburg, Russia

[3] Napalkov State Budgetary Healthcare Inst, Abdominal Oncol, St Petersburg Clin Sci & Pract Ctr Specialized Ty, St Petersburg, Russia

[4] Napalkov State Budgetary Healthcare Inst, Dept Pathol, St Petersburg Clin Sci & Pract Ctr Specialized Ty, St Petersburg, Russia

[5] Napalkov State Budgetary Healthcare Inst, Dept Radiol, St Petersburg Clin Sci & Pract Ctr Specialized Ty, St Petersburg, Russia

[6] Napalkov State Budgetary Healthcare Inst, Diagnost Dept, St Petersburg Clin Sci & Pract Ctr Specialized Ty, St Petersburg, Russia

[7] NN Blokhin Natl Med Res Ctr Oncol, Dept Chemotherapy, Moscow, Russia

[8] St Petersburg State Healthcare Inst, Dept Chemotherapy, City Clin Oncol Ctr, St Petersburg, Russia

[9] St Petersburg State Healthcare Inst, Dept Oncol, City Clin Oncol Ctr, St Petersburg, Russia

[10] St Petersburg State Healthcare Inst, Abdominal Oncol, City Clin Oncol Ctr, St Petersburg, Russia

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.362

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

450P

引用

页码：S180 / S181

页数：2

共 50 条

[1] Early and easy-to-retrieve predictive biomarkers of resistance to immunotherapy in microsatellite instability (MSI)/mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC)
Vaghi, C.
Ros Montana, F. J.
Mambrilla, M.
Navarro Garces, V.
Comas, R.
Salva Ballabrera, F.
Baraibar Argota, I.
Saoudi Gonzalez, N.
Rodriguez Castells, M.
Garcia Rodriguez, A.
Alcaraz, A.
Tabernero, J.
Elez Fernandez, M. E.
ANNALS OF ONCOLOGY, 2024, 35 : S56 - S57
[2] Clinicopathological and genomic characteristics of DNA Mismatch Repair-Deficient (dMMR) and microsatellite instability-high (MSI-H) resected gastric adenocarcinoma
Zhou, J.
Liang, B.
Yin, M.
Zhang, H.
Liu, F.
Dong, L.
Zhang, B.
Xu, Y.
ANNALS OF ONCOLOGY, 2020, 31 : S921 - S922
[3] Do microsatellite instability (MSI) and deficient mismatch repair (dMMR) affect the pathologic complete response (pCR) in patients with rectal cancer who received neoadjuvant treatment?
Turan Acar
Nihan Acar
Erdinç Kamer
Mustafa Agah Tekindal
Fevzi Cengiz
Haldun Kar
Kemal Atahan
Mehmet Haciyanli
Updates in Surgery, 2020, 72 : 73 - 82
[4] Do microsatellite instability (MSI) and deficient mismatch repair (dMMR) affect the pathologic complete response (pCR) in patients with rectal cancer who received neoadjuvant treatment?
Acar, Turan
Acar, Nihan
Kamer, Erdinc
Tekindal, Mustafa Agah
Cengiz, Fevzi
Kar, Haldun
Atahan, Kemal
Haciyanli, Mehmet
UPDATES IN SURGERY, 2020, 72 (01) : 73 - 82
[5] Epidemiology of Microsatellite Instability High (MSI-H) and Deficient Mismatch Repair (dMMR) in Solid Tumors: A Structured Literature Review
Lorenzi, Maria
Amonkar, Mayur
Zhang, Jacky
Mehta, Shivani
Liaw, Kai-Li
JOURNAL OF ONCOLOGY, 2020, 2020
[6] The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world.
Chakrabarti, Sakti
Parish, Marie
Peterson, Carrie
Ludwig, Kirk A.
Sriram, Deepika
Ruggeri, Antony
Tolay, Sameer
Selfridge, Jennifer Eva
Bajor, David L.
Mohamed, Amr
Mahipal, Amit
Shreenivas, Aditya V.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 105 - 105
[7] STRUCTURED LITERATURE REVIEW OF THE PREVALENCE OF MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS
Lorenzi, M.
Amonkar, M.
Zhang, J.
Mehta, S.
Liaw, K.
VALUE IN HEALTH, 2018, 21 : S22 - S23
[8] Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients (pts) with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma (OGA): The GERCOR NEONIPIGA phase II study
Andre, Thierry
Tougeron, David
Piessen, Guillaume
De La Fouchardiere, Christelle
Louvet, Christophe
Adenis, Antoine
Jary, Marine
Tournigand, Christophe
Aparicio, Thomas
Desrame, Jerome
Lievre, Astrid
Garcia-Larnicol, Marie-Line
Pudlarz, Thomas
Henriques, Julie
Cohen, Romain
Lefevre, Jeremie
Svrcek, Magali
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[9] Neoadjuvant nivolumab plus ipilimumab in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) rectal tumors: ECOG-ACRIN EA2201
Ciombor, K. K.
Hong, S.
Eng, C.
Yao, X.
You, N.
Das, P.
Chakravarthy, A.
O'Dwyer, P. J.
ANNALS OF ONCOLOGY, 2024, 35 : S104 - S104
[10] Literature review and meta-analyses of the prevalence of microsatellite instability high (MSI-H) and deficient mismatch repair (dMMR) for colorectal (CRC), gastric (GC), endometrial (EC) and ovarian cancers (OC) in Chinese population
Liu, Xiaoqiao
Fan, Jiaqi
Liaw, Kai-Li
Xu, Mo
Zhou, Yu
Amonkar, Mayur
Zeng, Gefei
CANCER RESEARCH, 2019, 79 (13)

← 1 2 3 4 5 →